Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Mar 2023 for Opiant Pharmaceuticals, INC., €361k.
Filing timeline
BuySaleMatthew R. Ruth
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew R. Ruth: trading record in brief
Matthew R. Ruth, listed as senior executive, appears in our data through filings on Opiant Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 19 July 2021 and 2 March 2023, the trades on record add up to 9 filings.
Market trades split into 1 purchase (€29k) and 1 sale (€11k). On balance, insiders were net buyers of €18k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants.
On 3 March 2023 came the latest disclosure, a transaction for €200k in Opiant Pharmaceuticals, Inc. The last insider purchase was made public on 1 September 2021, 1,879 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew R. Ruth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
19,250 shares@ US$20.0089.9% of flowCommon StockSEC:0001385508-23-000073:0
1,084 shares@ US$10.622.8% of flowCommon StockSEC:0001385508-22-000114:0
2,000 shares0Common StockSEC:0001385508-22-000099:0
12,000 shares0Common StockSEC:0001385508-22-000009:0
2,000 shares@ US$17.347.3% of flowCommon StockSEC:0001385508-21-000121:0
Canonical exit: 29 Nov 2021 (T+90)
15,000 shares0Common StockSEC:0001385508-21-000096:0
6 of 6 declarations
